BIO vs KLAC · rev $651.0M vs P/E 55, rev $13.58B
BIO (BIO) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
BIO currently screens at market cap $0. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the BIO and KLAC stock pages for the full models.
Not investment advice.